Invesaro

Stocks PGNY DCF valuation

DCF valuation

What is Progyny, Inc. worth?

With the base-case assumptions below, a discounted cash flow model on Progyny, Inc.'s reported free cash flow gives $72.21 per share. The share price was $25.44 on September 25, 2026, 65% below that value.

Inputs from the filings

Free cash flow, fiscal 2025
$191.8M
Average free cash flow, last 5 years
$130.3M
Cash
$152.6M
balance sheet of June 30, 2026
Debt
$0
not reported, counted as 0
Diluted shares, fiscal 2025
89,861,843
Revenue growth per year, last 5 years
30.2%

Three sets of assumptions

CaseGrowth yrs 1-5Growth yrs 6-10After year 10Discount rateValue per shareValue vs price
Bear10.0%6.0%2.0%10.0%$44.54+75%
Base15.0%9.0%2.5%9.0%$72.21+184%
Bull20.0%11.5%3.0%8.0%$123.73+386%

Sensitivity: base case value per share

Discount rate down the side, growth after year 10 across the top. Everything else as in the base case.

1.5%2.0%2.5%3.0%3.5%
7.0%$93.16$99.69$107.67$117.65$130.48
8.0%$77.42$81.66$86.66$92.67$100.01
9.0%$65.97$68.87$72.21$76.11$80.72
10.0%$57.29$59.35$61.68$64.35$67.43
11.0%$50.50$52.01$53.69$55.59$57.75

Where the presets come from

Base: years 1 to 5 grow at Progyny, Inc.'s revenue growth rate over the last 5 fiscal years (30.2% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.

Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.

Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.

This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.

Adjust the assumptions

Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.

Adjust the assumptions

Progyny, Inc. company page